Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy

BACKGROUND: Loss of HLA class I is important in ovarian cancer prognosis but its role as a prognostic indicator in relation to therapy remains unproven. We studied the prognostic potential of this antigen and its significance in relation to platinum therapy. METHODS: A total of 157 primary ovarian c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehata, M, Mukherjee, A, Deen, S, Al-Attar, A, Durrant, L G, Chan, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768455/
https://www.ncbi.nlm.nih.gov/pubmed/19755991
http://dx.doi.org/10.1038/sj.bjc.6605315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768455/
https://www.ncbi.nlm.nih.gov/pubmed/19755991
http://dx.doi.org/10.1038/sj.bjc.6605315

Ejemplares similares